Compare Langgeng Makmur Industri Tbk. (LMPI) vs Medela Potentia Tbk. (MDLA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Langgeng Makmur Industri Tbk. vs Medela Potentia Tbk. — how do they compare? Langgeng Makmur Industri Tbk. trades at Rp158 (market cap 162.37B, 354.9K 24h volume), while Medela Potentia Tbk. trades at Rp208 (market cap 2.91T, 5.49M 24h volume). The key difference: Medela Potentia Tbk. is far larger — about 17.9× Langgeng Makmur Industri Tbk.'s market cap, and Medela Potentia Tbk. is more actively traded (5.49M versus 354.9K). Which is the better fit depends on your goals.
| LMPI | MDLA | |
|---|---|---|
Market Cap | 162.37B | 2.91T |
Volume | 354.9K | 5.49M |
Lot | 3.55K | 54.88K |
Turnover | 56.05M | 1.14B |
Average Price | 157.92 | 208.24 |
Value | 56.05M | 1.14B |
Indicative Equilibrium Price | 158 | 208 |
Indicative Equilibrium Volume | 35 | 50 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Langgeng Makmur Industri Tbk.
PT. Langgeng Makmur Industri TBk (the Company) was established under the Domestic Capital Investment Law No. 6 of 1968 as amended by Law No. 12 of 1970, based on the Notarial Deed No. 40 dated November 30, 1972 of Kho Boen Tian, S.H., which was amended by Notarial Deed No. 3 dated January 7, 1976 of the same notary concerning the change in the Company name from PT Langgeng Jaya Plastic Industry Ltd., to PT Langgeng Makmur Plastic Industry Ltd. Based on Notarial Deed No. 450 dated June 27, 1997 of Adam Kasdarmadji, S.H., the Company's name has been changed, to PT Langgeng Makmur Industri Tbk.
Read more on LMPI →About Medela Potentia Tbk.
PT Medela Potentia Tbk. (Company) was established based on Deed of Establishment No. 04 dated August 5, 2011, of Public Notary Evy Ferdiana, S.H, Notary of Bekasi Regency, domiciled in Lemah Abang. The Company started its operation activities in 2013.
Read more on MDLA →
